ACTU vs CLOV
Actuate Therapeutics, Inc. Common stock (ACTU) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
ACTU does not have a complete income-statement cache yet.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ACTU currently screens at market cap $49.0M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ACTU and CLOV stock pages for the full models.
Not investment advice.